Linked Life Data

15313950

Source:http://linkedlifedata.com/resource/pubmed/id/15313950

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2004-9-1
pubmed:abstractText
Experimental studies revealed proinflammatory properties of angiotensin II. We evaluated antiinflammatory effects of the angiotensin II subtype 1 receptor antagonist olmesartan medoxomil alone and in cotherapy with the HMG-CoA reductase inhibitor pravastatin in patients with essential hypertension and microinflammation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/CCL2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL2, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Adhesion Molecule-1, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6, http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Pravastatin, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1, http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/olmesartan medoxomil
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1524-4539
pubmed:author
pubmed:issnType
Electronic
pubmed:day
31
pubmed:volume
110
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1103-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15313950-Aged, pubmed-meshheading:15313950-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:15313950-Arteriosclerosis, pubmed-meshheading:15313950-Biological Markers, pubmed-meshheading:15313950-C-Reactive Protein, pubmed-meshheading:15313950-Chemokine CCL2, pubmed-meshheading:15313950-Cholesterol, pubmed-meshheading:15313950-Comorbidity, pubmed-meshheading:15313950-Diabetes Mellitus, Type 2, pubmed-meshheading:15313950-Double-Blind Method, pubmed-meshheading:15313950-Drug Therapy, Combination, pubmed-meshheading:15313950-Female, pubmed-meshheading:15313950-Humans, pubmed-meshheading:15313950-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:15313950-Hypertension, pubmed-meshheading:15313950-Imidazoles, pubmed-meshheading:15313950-Intercellular Adhesion Molecule-1, pubmed-meshheading:15313950-Interleukin-6, pubmed-meshheading:15313950-Lipids, pubmed-meshheading:15313950-Male, pubmed-meshheading:15313950-Middle Aged, pubmed-meshheading:15313950-Pravastatin, pubmed-meshheading:15313950-Prospective Studies, pubmed-meshheading:15313950-Receptor, Angiotensin, Type 1, pubmed-meshheading:15313950-Tetrazoles, pubmed-meshheading:15313950-Treatment Outcome, pubmed-meshheading:15313950-Tumor Necrosis Factor-alpha, pubmed-meshheading:15313950-Vasculitis
pubmed:year
2004
pubmed:articleTitle
Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation.
pubmed:affiliation
Division of Nephrology, Department of Internal Medicine, Medical School Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. fliser.danilo@mh-hannover.de
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III